With RXR, such as CAR, being involved in the pathogenesis of metabolic syndrome, the pan-activation of the permissive CAR/RXR heterodimer amplifies metabolic disorders induced by xenobiotics, as underlined by other authors [45]. The gene discussed is NR1I3; the disease is metabolic disease.